Literature DB >> 6107954

Hyperparathyroidism: a prerequisite for Zollinger-Ellison syndrome in multiple endocrine adenomatosis Type 1--report of a further family and a review of th literature.

J B Betts, B P O'Malley, F D Rosenthal.   

Abstract

A family with Multiple Endocrine Adenomatosis Type 1 (MEA 1) is described. Of the 59 members, 15 were affected. Zollinger-Ellison syndrome was present in six individuals of whom the five available for study had hyperparathyroidism. The youngest of these patients with Zollinger-Ellison Syndrome was 25 years old. Hyperparathyroidism alone was present in nine individuals of whom the eldest was 30 years old. Three other members had raised serum gastrin levels but lacked symptoms suggestive of Zollinger-Ellison syndrome and in these individuals, the serum calcium levels were normal. A review of the literature confirms the finding that, in MEA 1, Zollinger-Ellison syndrome has not been shown to occur in the absence of hypercalcaemia. Screening of affected members of such families can therefore be restricted to the measurements of serum calcium levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107954

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  4 in total

1.  Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.

Authors:  D Murphy; A Bishop; G Rindi; M N Murphy; G W Stamp; J Hanson; J M Polak; B Hogan
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

Review 2.  Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes.

Authors:  C A Stratakis
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

3.  Endocrine abnormalities in primary hyperparathyroidism.

Authors:  D V Hamilton; J S Pryor
Journal:  Postgrad Med J       Date:  1981-03       Impact factor: 2.401

4.  Menin-mediated regulation of miRNA biogenesis uncovers the IRS2 pathway as a target for regulating pancreatic beta cells.

Authors:  Buddha Gurung; Bryson W Katona; Xianxin Hua
Journal:  Oncoscience       Date:  2014-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.